Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
Shuguang Zuo, Min Wei, Tiancheng Xu, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 12, pp. e002843-e002843
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 299
Oncolytic virotherapy: basic principles, recent advances and future directions
Danni Lin, Yinan Shen, Tingbo Liang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 165
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 22
An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy
Shibing Wang, Yuxin Li, Chuning Xu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008431-e008431
Open Access | Times Cited: 21
Oncolytic vaccinia virus and cancer immunotherapy
Lihua Xu, Huihui Sun, Nicholas R. Lemoine, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 17
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Dequan Liu, Xiangyu Che, Xiaoxi Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1384-1384
Open Access | Times Cited: 34
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
Matin Ghasemi, Laleh Abbasi, Leila Ghanbari Naeini, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17
LAG‐3 : recent developments in combinational therapies in cancer
Aude Chavanton, Flavie Mialhe, Jimena Abrey, et al.
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2494-2505
Open Access | Times Cited: 8
Recent progress in combination therapy of oncolytic vaccinia virus
Seyedeh Nasim Mirbahari, Miles Da Silva, Abril Ixchel Muñoz Zúñiga, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
Mengyuan Li, Zhang Minghuan, Qian Ye, et al.
Cancer Biology and Medicine (2023), pp. 1-16
Open Access | Times Cited: 15
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
Charlotte Lovatt, Alan L. Parker
Cancers (2023) Vol. 15, Iss. 16, pp. 4178-4178
Open Access | Times Cited: 14
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: A narrative review
Yifu Liu, Zhicheng Zhang, Siyuan Wang, et al.
International Immunopharmacology (2022) Vol. 110, pp. 108900-108900
Closed Access | Times Cited: 22
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
Ester Blanco, Luisa Chocarro, Leticia Fernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2676-2676
Open Access | Times Cited: 11
The combination therapy of oncolytic virotherapy
Yue Wang, Mengying Zhu, Huanyu Chi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
The investigation of oncolytic viruses in the field of cancer therapy
Zijun Yuan, Yinping Zhang, Xiang Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Inhibition of programmed cell death by melanoma cell subpopulations reveals mechanisms of melanoma metastasis and potential therapeutic targets
Yuepeng An, Fu Zhao, Hongling Jia, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
Irreversible electroporation synergizes with oncolytic virus enhances the infiltration of cytotoxic T lymphocytes in the tumor immune microenvironment: a leap from focal therapy to immunotherapy for prostate cancer
Zhi-Yu Xia, Jia-Cheng Xiang, Jin‐Zhou Xu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e009794-e009794
Open Access
Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy
Guo Lin, Zhuoran Yao, Kai Kang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity
Zengpeng Li, Mengyuan Li, Yang Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009473-e009473
Open Access | Times Cited: 3
Research progress and development potential of oncolytic vaccinia virus
Xinyu Zhang, Jiangshan He, Yiming Shao
Chinese Medical Journal (2025)
Open Access
CD8+ T cell-based immunotherapy: Promising frontier in human diseases
Nu Quynh Chau Ton, Gitima Deka, Pil‐Hoon Park
Biochemical Pharmacology (2025), pp. 116909-116909
Closed Access
Page 1 - Next Page

Scroll to top